公司资料
Journey Medical Corporation 股价、新闻与催化剂
- 股票代码:
- DERM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
6.46 USD (-3.87%)
收盘价
最后更新: 2026年8月17日
166M USD
市值
股价为何变动
As of Aug 17, 2026, DERM closed down 3.87% at $6.46. No new same-company headline was identified in the current news window.
公司概览
Prescription Dermatology Company
Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.
Emrosi
Emrosi is an oral treatment for inflammatory lesions of rosacea and is central to Journey Medical's current commercial expansion. The product broadens the company's presence in a large chronic dermatology market.
Established Portfolio
Journey Medical markets nine branded prescription drugs for common skin conditions. This portfolio allows the same commercial infrastructure to support multiple products and physician relationships.
Focused Commercial Model
The company emphasizes targeted product acquisition and specialist promotion rather than maintaining a broad internal discovery platform. Journey Medical was founded by Fortress Biotech but operates as a separately listed company.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。